SAM.gov75N98026Q01067
Open
Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf
- Response deadline
- Sep 4, 2026 Due in 6 days
- Date posted
- Aug 28, 2026
- Source
- Open notice
Description
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
Classifications
Documents (1)
- Notice_of_Intent_co_review_1.pdf.pdf164 KBNot yet available
Contacts
- natalie.bruning@nih.gov+1 000 000 0000
Similar contracts
- Blood Donor Testing ServicesGeorgiaDue Sep 10, 2026
- Q301-- New Lab Staffing Contract Fiscal Year 2027-Path & LabTennesseeDue Sep 15, 2026
- Specialized hands-on laboratory training and proprietary molecular reagents.Due Aug 28, 2026
- Q301--Esoteric STAT Testing Services Indianapolis, IN 46202IndianaDue Sep 2, 2026
- Q301--36C259-26-AP-1918 | Prostate Testing Non-Invasive | VISN ContractCODue Sep 2, 2026
- Q301-- Molecular Thyroid TestingCODue Sep 10, 2026